Clinical Trial Update: Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa [NA]

View source ↗

Summary

Clinical trial update indicates the DEC LTS-2 skin patch diagnostic study for onchocerciasis (and loiasis) in Central Africa has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Loiasis
• Onchocerciasis

Drugs mentioned

• DEC LTS-2 Skin Patch (diethylcarbamazine)

Snippet

Sponsor: Center for Research on Filariasis and Other Tropical Diseases, Cameroon | Conditions: Onchocerciasis, Loiasis | NA | Status: WITHDRAWN